New device for delivering anti-inflammatory medication to the lungs for pain relief in COPD patients
A Novel Aerosolization and Inhalation Platform for the Pulmonary Delivery of Anti-inflammatory Agents to Distal Airways for the Enhanced Pain Management in Chronic Obstructive Pulmonary Disease (COPD)
This study is testing a new inhaler that delivers anti-inflammatory medicine straight to the deep parts of the lungs for people with COPD, helping to reduce pain and improve breathing by using smart technology to track the right dose for each person.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scientific Horizons Consulting LLC NIH-funded |
| Lab location | 1 site (Irvine, UNITED STATES) |
| Project ID | NIH-10819739 on NIH RePORTER |
What this research studies
This research focuses on developing a novel inhalation device designed to deliver anti-inflammatory medications directly to the deep lung areas affected by chronic obstructive pulmonary disease (COPD). The device uses advanced aerosolization technology to create optimized particle sizes for effective delivery, overcoming limitations of current inhalation methods. It features a built-in monitoring system that tracks dosage in real-time, allowing for personalized treatment. By targeting inflammation in the distal airways, this approach aims to alleviate pain associated with COPD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who experience pain related to lung inflammation.
Not a fit: Patients with COPD who do not experience significant pain or have contraindications to anti-inflammatory medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve pain management for patients with COPD by providing more effective delivery of anti-inflammatory treatments.
How similar studies have performed: While the approach of using aerosolized anti-inflammatory agents is established, the specific technology and device being developed in this research is novel and has not been widely tested.
Where this research is happening
Irvine, UNITED STATES
- Scientific Horizons Consulting LLC — Irvine, United States (Active)
Researchers
- Principal investigator: Gao, Xiang — Scientific Horizons Consulting LLC
- Study coordinator: Gao, Xiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.